PT2241318E - Método para tratamento da síndrome do cólon irritável, com predominância de obstipação - Google Patents

Método para tratamento da síndrome do cólon irritável, com predominância de obstipação

Info

Publication number
PT2241318E
PT2241318E PT10007687T PT10007687T PT2241318E PT 2241318 E PT2241318 E PT 2241318E PT 10007687 T PT10007687 T PT 10007687T PT 10007687 T PT10007687 T PT 10007687T PT 2241318 E PT2241318 E PT 2241318E
Authority
PT
Portugal
Prior art keywords
predominance
observation
treatment
irritable colon
colon syndrome
Prior art date
Application number
PT10007687T
Other languages
English (en)
Portuguese (pt)
Inventor
Barry Quart
David Rosenbaum
Original Assignee
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Napo Pharmaceuticals Inc filed Critical Napo Pharmaceuticals Inc
Publication of PT2241318E publication Critical patent/PT2241318E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT10007687T 2006-05-01 2007-04-30 Método para tratamento da síndrome do cólon irritável, com predominância de obstipação PT2241318E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79707606P 2006-05-01 2006-05-01

Publications (1)

Publication Number Publication Date
PT2241318E true PT2241318E (pt) 2013-03-18

Family

ID=38668465

Family Applications (1)

Application Number Title Priority Date Filing Date
PT10007687T PT2241318E (pt) 2006-05-01 2007-04-30 Método para tratamento da síndrome do cólon irritável, com predominância de obstipação

Country Status (18)

Country Link
US (3) US7556831B2 (cg-RX-API-DMAC7.html)
EP (2) EP2015639A4 (cg-RX-API-DMAC7.html)
JP (2) JP2009535419A (cg-RX-API-DMAC7.html)
KR (2) KR20090009292A (cg-RX-API-DMAC7.html)
AU (1) AU2007248182B2 (cg-RX-API-DMAC7.html)
CA (1) CA2650022C (cg-RX-API-DMAC7.html)
CY (1) CY1113723T1 (cg-RX-API-DMAC7.html)
DK (1) DK2241318T3 (cg-RX-API-DMAC7.html)
ES (1) ES2401366T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20130203T1 (cg-RX-API-DMAC7.html)
MX (1) MX2008013768A (cg-RX-API-DMAC7.html)
NZ (3) NZ572049A (cg-RX-API-DMAC7.html)
PL (1) PL2241318T3 (cg-RX-API-DMAC7.html)
PT (1) PT2241318E (cg-RX-API-DMAC7.html)
RS (1) RS52678B (cg-RX-API-DMAC7.html)
SG (2) SG161259A1 (cg-RX-API-DMAC7.html)
SI (1) SI2241318T1 (cg-RX-API-DMAC7.html)
WO (1) WO2007130892A2 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ572049A (en) 2006-05-01 2012-08-31 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
PT2529626T (pt) 2006-05-01 2018-02-27 Napo Pharmaceuticals Inc Composições e métodos para tratamento ou prevenção do cancro do cólon
US8436051B2 (en) 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8734867B2 (en) 2007-12-28 2014-05-27 Liveleaf, Inc. Antibacterial having an extract of pomegranate combined with hydrogen peroxide
US8236838B2 (en) * 2008-04-21 2012-08-07 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
EP2278879B1 (en) 2008-04-21 2016-06-15 PATH Drug Solutions Compounds, compositions and methods comprising oxadiazole derivatives
US20090270398A1 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
WO2009131958A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising triazine derivatives
JP2012503005A (ja) * 2008-09-19 2012-02-02 インスティテュート フォア ワンワールド ヘルス イミダゾール誘導体およびトリアゾール誘導体を含む、化合物、組成物ならびに方法。
JP4565219B2 (ja) * 2008-12-26 2010-10-20 アサヒビール株式会社 ポリフェノール含有顆粒またはポリフェノール含有チュアブル錠剤およびその製造方法
SG10201503255SA (en) 2009-03-04 2015-06-29 Liveleaf Inc Method and material for site activated complexing of biologic molecules
US8511216B2 (en) * 2009-03-30 2013-08-20 Kanzaki Kokyukoki Mfg. Co., Ltd. Hydraulic actuator unit
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
AU2010303577B2 (en) * 2009-10-06 2015-10-22 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
WO2012058664A1 (en) 2010-10-31 2012-05-03 Salix Pharmaceuticals, Ltd. Methods and compositions for treating hiv-associated diarrhea
US20120329736A1 (en) * 2011-06-24 2012-12-27 Huang Alexander L Treatment for gastrointestinal disorders using a selective, site-activated binding system
US9192635B2 (en) 2011-06-24 2015-11-24 Liveleaf, Inc. Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide
US8722040B2 (en) 2011-06-24 2014-05-13 Liveleaf, Inc. Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
EP2922557B1 (en) * 2012-11-21 2017-10-04 KBS Research, LLC Herbal supplements and methods of use thereof
US8716351B1 (en) 2012-12-23 2014-05-06 Liveleaf, Inc. Methods of treating gastrointestinal spasms
US9510880B2 (en) 2013-08-13 2016-12-06 Zimmer, Inc. Polyaxial locking mechanism
US20170119834A1 (en) * 2014-05-29 2017-05-04 Jaguar Animal Health, Inc. Methods of Treating Diarrhea in Adult Non-Human Animals
US10282369B2 (en) * 2017-03-08 2019-05-07 Centri Technology, Inc. Fast indexing and searching of encoded documents
JP2020525407A (ja) 2017-05-31 2020-08-27 ナポ ファーマシューティカルズ インク.Napo Pharmaceuticals,Inc. 先天性下痢障害を治療するための方法及び組成物
AU2018275685B2 (en) 2017-05-31 2025-04-17 Napo Pharmaceuticals, Inc. Methods and compositions for treating bile acid diarrhea, diarrhea associated with small intestine resection or gallbladder removal, and short bowel syndrome
AU2018253466B2 (en) * 2017-07-17 2019-03-28 smartDNA Pty Ltd Method of diagnosing a dysbiosis
WO2026028258A1 (ja) * 2024-07-29 2026-02-05 BGG Japan株式会社 便通改善用の組成物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE446940B (sv) 1983-02-16 1986-10-20 Carl Axel Virdalm Medel for bekempande av sjukdomstillstand i matsmeltningsapparaten innehallande skal eller ytterdelar av ber eller frukter
US4698360B1 (en) 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
EP0214317B1 (fr) 1985-08-30 1988-08-17 Societe Des Produits Nestle S.A. Produit diététique à activité dépurative et anti-diarrhéique et son procédé de préparation
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
SI9011933A (sl) 1990-10-15 1998-06-30 TANIN SEVNICA Kemična industrija p.o. Kostanjev taninski ekstrakt, postopek za njegovo pridobivanje in njegova uporaba
US5234922A (en) 1992-09-28 1993-08-10 University Of Iowa Research Foundation Use of sulfonylureas and other potassium channel regulators to treat secretory diarrhea
JP4195728B2 (ja) * 1996-10-16 2008-12-10 ナポ ファーマシューティカルズ,インコーポレーテッド プロアントシアニジンポリマー止瀉組成物の腸溶製剤
AU6967198A (en) 1997-04-10 1998-10-30 Eli Lilly And Company Diarylsulfonylureas for use in treating secretory diarrhea
CN1215561A (zh) * 1997-10-27 1999-05-05 邢文海 保健茶
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
WO2000047062A2 (en) 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
CN1159054C (zh) 2002-01-22 2004-07-28 随志化 通腑止泻剂
US7235573B2 (en) 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
US20040063695A1 (en) 2002-09-30 2004-04-01 Alan Verkman Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
US7208183B2 (en) 2002-10-05 2007-04-24 Bobrowski Paul J Methods and preparations of the latex from the croton species
US7303772B2 (en) * 2005-11-10 2007-12-04 Olalde Rangel Jose Angel Synergistic phytoceutical compositions
PT2529626T (pt) 2006-05-01 2018-02-27 Napo Pharmaceuticals Inc Composições e métodos para tratamento ou prevenção do cancro do cólon
NZ572049A (en) 2006-05-01 2012-08-31 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
AU2010303577B2 (en) 2009-10-06 2015-10-22 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
WO2012058664A1 (en) 2010-10-31 2012-05-03 Salix Pharmaceuticals, Ltd. Methods and compositions for treating hiv-associated diarrhea
JP2016505561A (ja) 2012-12-07 2016-02-25 サリックス ファーマスーティカルズ,リミテッド Hiv関連下痢を治療する方法および組成物

Also Published As

Publication number Publication date
CA2650022C (en) 2017-05-16
WO2007130892A3 (en) 2008-10-30
SG195538A1 (en) 2013-12-30
RS52678B (sr) 2013-06-28
US20090238901A1 (en) 2009-09-24
JP2014058548A (ja) 2014-04-03
EP2015639A4 (en) 2009-11-25
EP2241318A1 (en) 2010-10-20
US20120128797A1 (en) 2012-05-24
NZ595679A (en) 2013-04-26
KR20090009292A (ko) 2009-01-22
EP2241318B1 (en) 2012-12-19
MX2008013768A (es) 2009-02-03
WO2007130892A2 (en) 2007-11-15
AU2007248182A1 (en) 2007-11-15
HK1143541A1 (en) 2011-01-07
US9138450B2 (en) 2015-09-22
HRP20130203T1 (hr) 2013-04-30
KR20130067317A (ko) 2013-06-21
SG161259A1 (en) 2010-05-27
AU2007248182B2 (en) 2013-05-23
PL2241318T3 (pl) 2013-05-31
CY1113723T1 (el) 2016-06-22
CA2650022A1 (en) 2007-11-15
US20080031983A1 (en) 2008-02-07
ES2401366T3 (es) 2013-04-19
NZ609280A (en) 2014-09-26
US7556831B2 (en) 2009-07-07
US8067041B2 (en) 2011-11-29
NZ572049A (en) 2012-08-31
DK2241318T3 (da) 2013-01-21
SI2241318T1 (sl) 2013-04-30
JP2009535419A (ja) 2009-10-01
EP2015639A2 (en) 2009-01-21

Similar Documents

Publication Publication Date Title
PT2034844T (pt) Método para o tratamento de síndrome do intestino irritável com predominância de diarreia
PT2252148T (pt) Métodos de tratamento da síndrome do intestino irritável
BRPI0820139A2 (pt) Composição antiperspirante ativa, e, processo de obtenção de uma composição antiperspirante ativa
BRPI0911077A2 (pt) método para tratamento de biomassa
PL2190883T3 (pl) Sposób obróbki biomasy
EP2276795A4 (en) Processing biomass
BRPI0910854A2 (pt) métodos de tratamento
BRPI0909179A2 (pt) Composição farmacêutica, e, método de tratamento de uma doença autoimune.
BRPI0814941A2 (pt) Composição de tratamentode semente, e, método de tratamento de semente.
BRPI1007477A2 (pt) método, e, composição de tratamento de poço
BRPI0910259A2 (pt) métodos de tratamento de inflamação
BRPI1008021A2 (pt) Método para fabricação de 2,6-dioxabiciclo-(3.3.0)-octano-4,8-diona
BRPI0919281A2 (pt) processo e sistema de lubrificacao de uma turbomáquina, e, turbomáquina
BRPI0716466A2 (pt) Tratamento da calda de açúcar
BRPI0906249A2 (pt) Processo de elaboração de 1,1,1,4,4,4-hexafluoro-2-buteno
BRPI0809690A2 (pt) Composição de lubrificante, e, método
BRPI0813569A2 (pt) Método de inspeção.
BRPI1006145A2 (pt) "composição e método para tratamento de diabetes".
BRPI1011012A2 (pt) composição de lubrificante, e, método
BRPI0821652A2 (pt) tratamento de biocombustíveis
BRPI0911577A2 (pt) derivados espiro-indol para o tratamento de doenças parasíticas.
FR2934493B1 (fr) Procede de taitement des fibres keratiniques humaines.
BRPI0715728A2 (pt) tratamento de distérbio cartilaginosos
BRPI0917417A2 (pt) mnétodos de tratar deficiência cognitiva
BR112012004676A2 (pt) método de tratar infecções orotomixovirais.